Avanos Medical Statistics
Total Valuation
Avanos Medical has a market cap or net worth of $653.70 million. The enterprise value is $721.73 million.
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Avanos Medical has 46.00 million shares outstanding. The number of shares has decreased by -1.29% in one year.
Current Share Class | 46.00M |
Shares Outstanding | 46.00M |
Shares Change (YoY) | -1.29% |
Shares Change (QoQ) | -1.29% |
Owned by Insiders (%) | 1.74% |
Owned by Institutions (%) | 88.40% |
Float | 42.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 12.74 |
PS Ratio | 0.96 |
Forward PS | 0.95 |
PB Ratio | 0.79 |
P/TBV Ratio | 2.53 |
P/FCF Ratio | 7.95 |
P/OCF Ratio | 6.55 |
PEG Ratio | 1.46 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 8.71.
EV / Earnings | n/a |
EV / Sales | 1.05 |
EV / EBITDA | 7.99 |
EV / EBIT | 16.11 |
EV / FCF | 8.71 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.21.
Current Ratio | 2.37 |
Quick Ratio | 1.45 |
Debt / Equity | 0.21 |
Debt / EBITDA | 1.63 |
Debt / FCF | 2.05 |
Interest Coverage | 3.67 |
Financial Efficiency
Return on equity (ROE) is -37.42% and return on invested capital (ROIC) is 2.29%.
Return on Equity (ROE) | -37.42% |
Return on Assets (ROA) | 1.97% |
Return on Invested Capital (ROIC) | 2.29% |
Return on Capital Employed (ROCE) | 4.53% |
Revenue Per Employee | $308,846 |
Profits Per Employee | -$176,066 |
Employee Count | 2,227 |
Asset Turnover | 0.48 |
Inventory Turnover | 2.03 |
Taxes
Income Tax | -17.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.03% in the last 52 weeks. The beta is 1.17, so Avanos Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.17 |
52-Week Price Change | -28.03% |
50-Day Moving Average | 15.61 |
200-Day Moving Average | 19.50 |
Relative Strength Index (RSI) | 39.57 |
Average Volume (20 Days) | 529,126 |
Short Selling Information
The latest short interest is 796,523, so 1.73% of the outstanding shares have been sold short.
Short Interest | 796,523 |
Short Previous Month | 706,950 |
Short % of Shares Out | 1.73% |
Short % of Float | 1.89% |
Short Ratio (days to cover) | 1.62 |
Income Statement
In the last 12 months, Avanos Medical had revenue of $687.80 million and -$392.10 million in losses. Loss per share was -$8.53.
Revenue | 687.80M |
Gross Profit | 381.30M |
Operating Income | 44.80M |
Pretax Income | 14.70M |
Net Income | -392.10M |
EBITDA | 90.30M |
EBIT | 44.80M |
Loss Per Share | -$8.53 |
Full Income Statement Balance Sheet
The company has $107.70 million in cash and $170.20 million in debt, giving a net cash position of -$62.50 million or -$1.36 per share.
Cash & Cash Equivalents | 107.70M |
Total Debt | 170.20M |
Net Cash | -62.50M |
Net Cash Per Share | -$1.36 |
Equity (Book Value) | 828.50M |
Book Value Per Share | 18.03 |
Working Capital | 227.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $100.70 million and capital expenditures -$17.80 million, giving a free cash flow of $82.90 million.
Operating Cash Flow | 100.70M |
Capital Expenditures | -17.80M |
Free Cash Flow | 82.90M |
FCF Per Share | $1.80 |
Full Cash Flow Statement Margins
Gross margin is 55.44%, with operating and profit margins of 6.51% and -57.01%.
Gross Margin | 55.44% |
Operating Margin | 6.51% |
Pretax Margin | -58.64% |
Profit Margin | -57.01% |
EBITDA Margin | 13.13% |
EBIT Margin | 6.51% |
FCF Margin | 12.05% |